Florida Companies Settle Claims That GLP-1 Drug Sales Violated Connecticut Law
HARTFORD, Conn. — Florida companies have settled allegations that they violated Connecticut law by selling research grade semaglutide and tirzepatide directly to consumers in the state as weight loss medications that...To view the full article, register now.
Already a subscriber? Click here to view full article